Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure

Pediatric Critical Care Medicine

Volumn 6, Issue 2, 2005, Pages 160-165

  Thomas, Neal J ^a,b   Hollenbeak, Christopher S ^b   Lucking, Steven E ^a   Wilson, Douglas F ^c  

^a PENN STATE CHILDREN S HOSPITAL   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acute hypoxemic respiratory failure; Cost effectiveness; Costs and cost analysis; Medical decision making; Surfactant

Indexed keywords

CALFACTANT;

ACUTE RESPIRATORY FAILURE; ARTICLE; BODY WEIGHT; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG PACKAGING; HEALTH CARE COST; HUMAN; INTENSIVE CARE UNIT; MULTICENTER STUDY; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESOURCE ALLOCATION; STANDARDIZATION; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; ANOXEMIA; BIOLOGICAL PRODUCTS; CHILD; COST-BENEFIT ANALYSIS; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MARKOV CHAINS; MODELS, ECONOMIC; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 19444377118     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000154965.08432.16     Document Type: Article

References (22)

1. Holm BA, Notter RH, Seigle J, et al: Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985; 59:1402-1409
2. Petty TL, Silvers W, Paul GW, et al: Abnormalities in the lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 1979; 74:571-574
3. Pison U, Seeger W, Buchhorn R, et al: Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989; 140:1033-1039
4. Arnold JH, Hanson JH, Toro-Figuero LO, et al: Prospective, randomized comparison of high frequency oscillatory ventilation and conventional mechanical ventilation in paediatric respiratory failure. Crit Care Med 1994; 22:1530-1539
5. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 149:295-305
6. Hickling KG, Walsh J, Henderson S, et al: Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 1994; 22:1568-1578
7. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
8. Murdoch IA, Storman MO: Improved arterial oxygenation in children with the adult respiratory distress syndrome: The prone position. Acta Paediatr 1994; 83:1043-1046
9. Moler FW, Custer JR, Bartlett RH, et al: Extracorporeal life support for severe paediatric respiratory failure: An update experience, 1991-1993. J Pediatr 1994; 124:875-880
10. Horbar JD, Soll RF, Sutherland JM, et al: A multicenter, randomized, placebo controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 1989; 320: 959-965
11. Kendig JW, Notter RH, Cox C, et al: Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics 1988; 82:756-762
12. Collaborative European Multicenter Study Group: Surfactant replacement for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics 1988; 82:683-691
13. Merritt TA, Hallman M, Bloom BT, et al: Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986; 315:785-790
14. Gitlin JD, Soll RF, Parad RB, et al: Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 1987; 79:31-37
15. Jobe A, Ikegami M, Glatz T, et al: Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest 1981; 67:370-375
16. Kattwinkel J, Bloom BT, Delmore P, et al: Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993; 92:90-98
17. Willson DF, Jiao JH, Bauman LA, et al: Calf's lung surfactant extract in acute hypoxic respiratory failure in children. Crit Care Med 1996; 24:1316-1322
18. Willson DF, Zaritsky A, Bauman LA, et al: Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med 1999; 27:188-195
19. Lopez-Herce J, de Lucas N, Angel C, et al: Surfactant treatment for acute respiratory distress syndrome. Arch Dis Child 1999; 80: 248-252
20. Tibby SM, Hatherill M, Wright SM, et al: Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000; 162:1251-1256
21. Nakamura CT, Ripka JF, McVeigh K, et al: Bronchoscopic instillation of surfactant in acute respiratory distress syndrome. Pediatr Pulmonol 2001; 31:317-320
22. Hermon MM, Golej J, Burda G, et al: Surfactant therapy in infants and children: Three years experience in a pediatric intensive care unit. Shock 2002; 17:247-251